Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod (P6-6.006)

Ludwig Kappos; Douglas L. Arnold; Chahin Pachaï; Nathanial R. Eddy; Jason Osik; Chun-Yen Cheng; Sarah Harris; Erik DeBoer; Léorah Freeman; Cristina Granziera; Massimo Filippi

doi:10.1212/wnl.0000000000204932

April 9, 2024Neurology

Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod (P6-6.006)

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

To use a machine learning (ML) model to predict long-term clinical disability progression (CDP) in patients with relapsing multiple sclerosis (RMS) treated with ozanimod.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kappos et al. (2024) studied this question.

synapsesocial.com/papers/68e6feb4b6db643587678b2e https://doi.org/10.1212/wnl.0000000000204932

View at Publisher

Ask AI

Bookmark

Share

Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod (P6-6.006)

Ask about this paper

Abstract

Discussion

Cite This Study

Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod (P6-6.006)

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading